Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors

Bone Marrow Transplantation

Volumn 21, Issue 5, 1998, Pages 461-471

  Lamb Jr , L S ^a,b   Gee, A P ^a   Henslee Downey, P J ^a   Geier, S S ^a   Hazlett, L ^a   Pati, A R ^a   Godder, K ^a   Abhyankar, S A ^a   Turner, M W ^a   Lee, C ^a   Harris, W G ^a   Parrish, R S ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Palmetto Richland Memorial Hospital   (United States)

Author keywords

Bone marrow transplantation; Flow cytometry; Haploidentical donor; Immune reconstitution; T cell depletion

Indexed keywords

CONCANAVALIN A; LYMPHOCYTE ANTIGEN; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN;

ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 2642703463     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701110     Document Type: Article

References (32)

1. Myers JD, Thomas ED. Infection complicating bone marrow transplantation. In: Rubin RH, Young LS (eds). Clinical Approach to Infection in the Immunocompromised Host. New York: Plenum, 1988, pp 525-556.
2. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209-226.
3. Ferrara JL, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
4. Henslee-Downey PJ, Parrish RS, Macdonald JS et al. Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant. Transplantation 1996; 61: 738-745.
5. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T cell-depleted 'three loci' incompatible transplant in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
6. Henslee-Downey PJ, Abhyankar SH, Parrish RS et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997; 89: 3864-3872.
7. Lamb LS, Szafer F, Henslee-Downey PJ et al. Characterization of acute bone marrow graft rejection in T cell depleted partially mismatched related donor bone marrow transplantation. Exp Hematol 1995; 23: 1595-1600.
8. Lamb L, Lee C, Gee A et al. Patterns of acute rejection following transplantation of partially matched bone marrow. Bone Marrow Transplant 1996; 17; 1021-1027.
9. Donohue J, Homage M, Kernan NA. Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor. Blood 1993; 82: 1023-1029.
10. Soiffer RJ, Gonon R, Murray C et al. Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic transplantation. Blood 1993; 82: 2216-2223.
11. Jennings D, Thompson JS, Henslee-Downey PJ et al. Immunophenotyping of peripheral blood lymphocytes in the diagnosis of acute graft-versus-host disease. Transplant Proc 1989; 21: 2999-3003.
12. Tittle TV, Weinberg AD, Steinkeler CN, Maziarz RT. Expression of the T cell activation antigen. OX-40, identifies alloreactive cells in acute graft-versus-host reaction. Blood 1997; 89: 4652-4658.
13. Lamb LS, Robbins NF, Abhyankar SA et al. Flow cytometric cell sorting combined with molecular chimerism analysis to detect minimal recurrent leukemia: good news and bad news. Bone Marrow Transplant 1997; 19: 1157-1161.
14. Lee C, Brouillette M, Lamb L et al. Use of a closed system for Vαβ-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation. Prog Clin Biol Sci 1994; 389: 523-532.
15. Kernan NA, Collins NH, Bleau SA, O'Reilly RJ. Evaluation of T cell depletion: limiting dilution analysis of clonable T cells - microtechnique. In: Aman E, Deeg HJ, Sacher RA (eds). Bone Marrow and Stem Cell Processing: A Manual of Current Techniques. FA Davis: New York; 1992, pp 427-439.
16. Henslee-Downey PJ. Mismatched bone marrow transplantation. Curr Opin Oncol 1995; 7: 115-121.
17. Henslee-Downey P. Alternative donors for bone marrow transplantation. In: Barrett J, Treleaven JG (eds). Clinical Practice of Stem Cell Transplantation (in press).
18. Syzdlo R, Goldman JM, Klein JP et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997; 15: 1747-1777.
19. Nademanee A, Schmidt GM, Parker P et al. The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporin, methotrexate, and prednisone. Blood 1995; 86: 1228-1234.
20. Sullivan KM, Mori M, Sanders J et al. Late complications of allogeneic and autologous bone marrow transplantation. Bone Marrow Transplant 1992; 10 (Suppl. 1): 127-134.
21. Ault K, Antin J, Ginsburg D et al. Phenotype of recovering cell populations after bone marrow transplantation. J Exp Med 1985; 161: 1483-1502.
22. Lum L. The kinetics of immune reconstitution after human bone marrow transplantation. Blood 1987; 69: 369-380.
23. Zintl F, Prager J, Sauerbrey A et al. Immunoreconstitution after human bone marrow transplantation. Folia Haematol 1989; 116: 519-526.
24. Keever C, Small T, Flomenberg N et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73: 1340-1350.
25. Smith F, Rencher S, Heslop H, Hurwitz J. T cell repertoire of CD4+ and CD8+ T cell subsets in the allogeneic bone marrow transplant patient. Cancer Immunol Immunother 1995; 41: 104-110.
26. Kook H, Goldman F, Padley D et al. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996; 88: 1089-1097.
27. Gratama M, Fibbe W, Visser J et al. CD3+, 4+ and/or 8+ T cells and CD3+, 4-, 8-T cells repopulate at different rates after allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 291-296.
28. Comoli P, Maccario D, Montagna D et al. Expression of the p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation. Clin Exp Immunol 1994; 97: 510-516.
29. Maino VC, Suni AA, Ruitenberg JJ. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 1995; 20: 127-133.
30. Mardiney M, Brown MR, Fleisher TA. Measurement of T cell CD69 expression: a rapid and efficient means to assess mitogen-or antigen-induced proliferative capacity in normals. Cytometry 1996; 26: 305-310.
31. + T cells in disease-free survivors following partially mismatched related donor bone marrow transplantation for leukemia. J Hematother 1996; 5: 503-509.
32. Lamb LS, Gee AP, O'Hanlon TP et al. Characterization of the TCR-γδ+ T cell population appearing in leukemia-free recipients of T cell depleted bone marrow grafts from partially mismatched related donors. Blood 1996; 88: 610a (Abstr).